Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoid Arthritis.
Xiaohui MengZechuan ChenTeng LiZhixing NieHaihui HanSheng ZhongZhinan YinSongtao SunJun XieJun ShenXirui XuChenxin GaoLei RanBo XuZheng XiangJianye WangPengfei SunPengfei XinXinyu AChengbo ZhangGuowei QiuHuali GaoYanqin BianMinglan XuBoran CaoFang LiLin ZhengXiaoming ZhangLian-Bo XiaoPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
The FGF pathway is a critical signaling pathway in relapse RA. Targeted tissue-specific inhibition of FGF10/FGFR1 may provide new opportunities to treat patients with relapse RA.
Keyphrases
- rheumatoid arthritis
- disease activity
- signaling pathway
- cancer therapy
- free survival
- ankylosing spondylitis
- interstitial lung disease
- acute lymphoblastic leukemia
- acute myeloid leukemia
- multiple myeloma
- diffuse large b cell lymphoma
- pi k akt
- hodgkin lymphoma
- epithelial mesenchymal transition
- drug delivery
- systemic sclerosis
- oxidative stress